You are about to exit the Consilient Health website to visit an independent third party website which is not under the control of Consilient Health. Consilient Health makes no warranties or representations of any kind as to the accuracy, completeness, reliability or usefulness of any information contained in third party sites and shall have no liability for any loss or damage of any kind that may arise from your use of such content or information.
Inclusion of any third party link does not imply an endorsement or recommendation by Consilient Health Ltd.
Please click ok if you wish to continue to the third party website or click cancel if you wish to return to altavita.ie.
The Touch Endocrinology Website provides healthcare professionals with practical, free-to-access, cutting-edge online education that supports best clinical practice.
Currax * have sponsored the following learning activity :
Speaker: Prof Carel Le Roux, Professor of Metabolic medicine, UCD, Dublin.
Overview:
Watch Prof. Carel le Roux outline the current evidence for the benefits and risks of pharmacological anti-obesity treatments, the implications of this evidence for primary care management, and the need to personalise treatment choices.
Click on the link below to view this educational resource
* Currax Pharmaceuticals are the manufacturer of Mysimba and one of Consilient Health’s Commercial Partners. (MAH: Orexigen) : www.curraxpharma.com
The information on this website is intended for Republic of Ireland residents only
MYS-0397-001 01 /25, IE-MYS-193, Date of preparation: February 2025
(function(t,e,s,n){var o,a,c;t.SMCX=t.SMCX||[],e.getElementById(n)||(o=e.getElementsByTagName(s),a=o[o.length-1],c=e.createElement(s),c.type="text/javascript",c.async=!0,c.id=n,c.src="https://widget.surveymonkey.com/collect/website/js/tRaiETqnLgj758hTBazgdws7k5QmnfCdd2cjjySZdrIUgzqN1wKhsoc33uvarp3E.js",a.parentNode.insertBefore(c,a))})(window,document,"script","smcx-sdk"); Create your own user feedback survey
